Greenway Nicola Deidre Petal: insider trades.
Greenway Nicola Deidre Petal reported 5 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($957K), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- Greenway Nicola Deidre Petal
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Takeda Pharmaceutical Co Ltd (TAK) | Officer · Chief Human Resources Officer | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-18 | Takeda Pharmaceutical Co Ltd | S | 12,980 | $18.11 | 40,049 | Form 4 |
| 2026-08-10 | Takeda Pharmaceutical Co Ltd | S | 33,628 | $17.51 | 59,803 | Form 4 |
| 2026-08-10 | Takeda Pharmaceutical Co Ltd | S | 975 | $17.5 | 93,431 | Form 4 |
| 2026-08-10 | Takeda Pharmaceutical Co Ltd | S | 6,774 | $17.1 | 53,029 | Form 4 |
| 2026-07-01 | Takeda Pharmaceutical Co Ltd | A | 22,570 | $0 | 94,406 | Form 4 |
Questions
What stock did Greenway Nicola Deidre Petal buy or sell?
Greenway Nicola Deidre Petal reported 5 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($957K), across 1 company.
Is Greenway Nicola Deidre Petal the same person as other filers with this name?
This page covers SEC CIK 2123546 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/greenway-nicola-deidre-petal-2123546.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.